SightfileU.S. market data from official filings

REVOLUTION MEDICINES INC (RVMD)

Name: REVOLUTION MEDICINES INC (RVMD) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001628171 · EDGAR filings · Updated 2026-07-01

REVOLUTION MEDICINES INC (RVMD) has reported institutional ownership of 93.3%, with 511 institutional managers holding positions valued at $19.1B per the latest 13F reporting period.

Institutional ownership

93.3%

Institutional managers

511

Reported 13F value

$19.1B

Insider activity

114 trans.

−$44.4M net selling

Latest updates

2026-07-01 — Insider transaction reported (Form 4)
2026-06-29 — Notice of proposed sale filed (Form 144)
2026-06-26 — Insider transaction reported (Form 4)
2026-06-24 — Notice of proposed sale filed (Form 144)
2026-06-23 — Insider transaction reported (Form 4)
2026-06-23 — Insider transaction reported (Form 4)
2026-06-23 — Insider transaction reported (Form 4)
2026-06-23 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, REVOLUTION MEDICINES INC has 511 institutional holders and institutional ownership of 93.3%.

#	Institution	Reported value	% of tracked total
1	FARALLON CAPITAL MANAGEMENT LLC	$1.32B	6.9%
2	BlackRock, Inc.	$1.09B	5.7%
3	JANUS HENDERSON GROUP PLC	$949.5M	5.0%
4	BAKER BROS. ADVISORS LP	$929.3M	4.9%
5	FMR LLC	$823.2M	4.3%
6	VANGUARD CAPITAL MANAGEMENT LLC	$813.2M	4.3%
7	Nextech Invest, Ltd.	$739.2M	3.9%
8	VANGUARD PORTFOLIO MANAGEMENT LLC	$729.6M	3.8%
9	Paradigm Biocapital Advisors LP	$647.3M	3.4%
10	WELLINGTON MANAGEMENT GROUP LLP	$586.2M	3.1%

Full holder history and quarter-over-quarter changes are available inside the app.

Insider activity

Insiders reported 114 transactions (0 buys, 69 sells) across 16 reporting insiders, with a net reported value of −$44.4M.

Quarterly net insider value, as reported in Form 4 filings.

Related companies

GSK PLC (GSK) · QUEST DIAGNOSTICS INC (DGX) · ILLUMINA INC (ILMN) · INCYTE CORP (INCY) · ZIMMER BIOMET HLDGS INC (ZBH) · ALCON AG (ALC)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-01.